Rybelsus: A brand of semaglutide in tablet form used to treat type 2 diabetes
Semaglutide or Tirzepatide cannot be prescribed to anyone with the following and should not be purchased: BMI under 27, eating disorder, gallbladder disease, drug or alcohol abuse, recent bariatric surgery, pancreatitis, medullary thyroid cancer, currently pregnant or breastfeeding, planning to become pregnant, Diabetic retinopathy, Multiple endocrine neoplasia type 2, or a family history of medullary thyroid carcinoma
Diamanti-Kandarakis E, Piperi C, Patsouris E, Korkolopoulou P, Panidis D, Pawelczyk L, et al
doi:10.3892/etm.2020.9029 Kobayashi R, Hasegawa M, Kawaguchi C, et al
Ingredientes L-carnitine L-tartrate (2:1), vegetable capsule [coating agent (hydroxypropylmethylcellulose)], rice flour, anti-caking agent (magnetic salts of fatty acids)